Randomized study comparing effects of oral hypoglycemic agents (nateglinide, acarbose) on daily glucose profile analyzed by 24-hour continuous glucose monitering system.

Trial Profile

Randomized study comparing effects of oral hypoglycemic agents (nateglinide, acarbose) on daily glucose profile analyzed by 24-hour continuous glucose monitering system.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Acarbose (Primary) ; Nateglinide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Sep 2011 Status changed from recruiting to completed.
    • 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
    • 16 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top